Female Stress Urinary Incontinence Treatment Devices Market Trends

Growth Drivers

• Increase in Instances of Urinary Incontinence - The incidence of urinary incontinence in women ranged between 10%-65% across the globe while the symptoms of this disease are observed to escalate with age, for instance, nearly 70% of women aged above 65 report urine leakage.

• Urinary incontinence is a condition in which the person losses the control over bladder and people are not much open-minded about this disease. Hence a higher number of women are in the need of proper treatment to cure this condition which is expected to propel the growth of the market over the forecast period.

• Rising Prevalence of Gynecological Disorders - In India alone, the percentage of women diagnosed with PCOS was estimated to be nearly 9% in 2021 while more than 12% of women in the United States suffer from it.

• Growing Incidence of Urinary Incontinence Due to Menopause - Each year about 1 million women attain menopause in the U.S.

• Rise in Incidence of Tuberculosis - As of 2020, the number of tuberculosis cases per 100,000 individuals was estimated to be around 7,174 globally.

• Increase of Medical Conditions such as Parkinson’s Disease, and Multiple Sclerosis - As the global estimates in 2019, over 8.5 million people have Parkinson’s disease which is further projected to be doubled in 25 years.

Challenges

• Emergence of Neuromodulator for Electric Stimulation of Nerves
• Limitation in Patients with the Fibrotic Urethra
• Poor Procedural Outcomes
• It is not necessary to get rid of stress urinary incontinence after receiving the proper treatment and the patients might have to continue taking the medicines or drugs. Hence, such uncertainty about the treatment is expected to hamper the growth of the market over the forecast period.